ArticleAIDS research and therapy2026
Examining facilitators, barriers, and social support in PrEP uptake and utilization for young African women: implications for HIV prevention.
Article in AIDS research and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAdolescent girls and young women (AGYW) in sub-Saharan Africa experience disproportionately high HIV incidence, making pre-exposure prophylaxis (PrEP) a critical prevention strategy. While perceived HIV risk is known to influence PrEP initiation and continuation, the role of social support in shaping PrEP use among AGYW remains insufficiently understood.
methodsThis study presents a secondary analysis of qualitative interview data collected as part of HPTN 082, an open-label PrEP trial conducted between 2016 and 2018 in Harare, Zimbabwe, and Cape Town and Johannesburg, South Africa. Participants were offered daily oral PrEP (tenofovir disoproxil fumarate/emtricitabine). Sixty-seven AGYW aged 16-24 were purposively sampled from the parent cohort of 426 participants, all of whom were identified as being at high risk for HIV using an empiric risk score. Participants completed in-depth interviews at 13 and/or 26 weeks following study enrollment and PrEP initiation. Interviews explored motivations for PrEP use, experiences of adherence, and social influences. Analysts conducted thematic analysis to examine how social support and perceived HIV risk shaped PrEP initiation, adherence, and discontinuation.
resultsThree interconnected themes emerged: (1) multidimensional social support influencing PrEP adherence, (2) stigma, privacy constraints, and constrained adherence, and (3) perceived HIV risk as a key motivator for PrEP initiation and continuation. Emotional, instrumental, informational, and normative forms of support facilitated adherence in some contexts, while stigma, anticipated judgment, and limited privacy within households led to concealment, missed doses, and discontinuation in others. Perceived HIV risk, particularly related to partner infidelity or uncertainty, motivated PrEP initiation and persistence despite social barriers.
conclusionsSocial support operates as a dynamic, double-edged influence on PrEP use among AGYW, simultaneously enabling and constraining adherence, depending on relational and structural contexts. Interventions that integrate stigma reduction, household- and community-level education, and strategies supporting autonomy and disclosure decision-making may improve sustained PrEP use. Addressing both social dynamics and risk perception remains critical to strengthening HIV prevention efforts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.